BAYN - Bayer AG NA - Stock Price & Dividends

Bayer AG, a global life science company, operates through three main segments: Pharmaceuticals, Consumer Health, and Crop Science.

The Pharmaceuticals segment is a leading developer of prescription medicines, focusing on cardiology and women's health care. It also specializes in specialty therapeutics for oncology, hematology, and ophthalmology, as well as diagnostic imaging equipment and digital solutions. Additionally, the segment is involved in cell and gene therapy, offering innovative treatments for various diseases.

The Consumer Health segment is a prominent player in the over-the-counter (OTC) medicines market, providing a range of self-medication and self-care products. Its portfolio includes nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health solutions. Furthermore, this segment is engaged in the breeding, propagation, and production/processing of seeds, including seed dressing, to support sustainable agriculture.

Bayer has established various collaborations with renowned institutions and companies, such as Acuitas Therapeutics, Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc. These partnerships aim to advance gene editing programs, basic pharmaceutical research, and the development of innovative treatments for various diseases.

The company distributes its products through a diverse network of wholesalers, pharmacies, supermarkets, online retailers, hospitals, and directly to farmers. Bayer has also partnered with Thermo Fisher Scientific to further expand its reach.

Founded in 1863, Bayer AG is headquartered in Leverkusen, Germany, and has a rich history of innovation and commitment to improving human and animal health, as well as crop yields. For more information, visit their website at https://www.bayer.com.